Screening for renal insufficiency following ESUR (European society of urogenital radiology) guidelines with on-site creatinine measurements in an outpatient setting

European Radiology

Volumn 20, Issue 8, 2010, Pages 1926-1933

  Ledermann, H P ^a   Mengiardi, B ^a   Schmid, A ^a   Froehlich, J M ^b,c  

^a IMAMED Radiologie Nordwest   (Switzerland)

^b Guerbet AG   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Contrast media toxicity; Glomerular filtration rate; Renal insufficiency; Risk management; Serum creatinine

Indexed keywords

CREATININE; IOBITRIDOL;

ADULT; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG DOSE REDUCTION; FEMALE; GLOMERULUS FILTRATION RATE; GOUT; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY SURGERY; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTPATIENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEINURIA; QUESTIONNAIRE; SCINTIGRAPHY;

AMBULATORY CARE; BIOLOGICAL MARKERS; CREATININE; EUROPE; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OUTPATIENTS; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; QUESTIONNAIRES; RENAL INSUFFICIENCY; RISK ASSESSMENT; RISK FACTORS; SWITZERLAND; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77957937859     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-010-1754-2     Document Type: Article

References (37)

1. Berg KJ (2000) Nephrotoxicity related to contrast media. Scand J Urol Nephrol 34:317-322
2. Becker CR, Reiser MF (2005) Use of iso-osmolar nonionic dimeric contrast media in multidetector row computed tomography angiography for patients with renal impairment. Invest Radiol 40:672-675
3. Nguyen SA, Suranyi P, Ravenel JG et al (2008) Iso-osmolality versus lowosmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function. Radiology 248:97-105
4. Thomsen HS, Morcos SK (2009) Risk of contrast-medium-induced nephropathy in high-risk patients undergoing MDCT-a pooled analysis of two randomized trials. Eur Radiol 19:891-897
5. Thomsen HS, Morcos SK (2005) In which patients should serum creatinine be measured before iodinated contrast medium administration? Eur Radiol 15:749-754
6. Byrd L, Sherman RL (1979) Radiocontrast-induced acute renal failure: a clinical and pathophysiologic review. Medicine (Baltimore) 58:270-279
7. Choyke PL, Cady J, DePollar SL, Austin H (1998) Determination of serum creatinine prior to iodinated contrast media: is it necessary in all patients? Tech Urol 4:65-69
8. Tippins RB, Torres WE, Baumgartner BR, Baumgarten DA (2000) Are screening serum creatinine levels necessary prior to outpatient CT examinations? Radiology 216:481-484
9. Olsen JC, Salomon B (1996) Utility of the creatinine prior to intravenous contrast studies in the emergency department. J Emerg Med 14:543-546
10. ESUR (2009) ESUR guidelines on contrast media, version 7.0. http://www.esur.org/ESUR-Guidelines.23.0.html. Accessed 24 February 2010
11. ACR (2008) ACR manual on contrast media, version 6. http://www.acr.org/ SecondaryMainMenuCategories/quality-safety/contrast-manual.aspx. Accessed 24 February 2010
12. Dols JL, Sanders GT (1993) Evaluation of the creatinine assay on the Reflotron analyser under centralized and non-centralized conditions. Eur J Clin Chem Clin Biochem 31:359-366
13. Bostom AG, Kronenberg F, Ritz E (2002) Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels. J Am Soc Nephrol 13:2140-2144
14. K/DOQI (2002) Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39: S1-266
15. Levey AS, Coresh J, Balk E et al (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139:137-147
16. Nyman U, Almen T, Aspelin P, Hellstrom M, Kristiansson M, Sterner G (2005) Contrast-medium-induced nephropathy correlated to the ratio between dose in gram iodine and estimated GFR in ml/min. Acta Radiol 46:830-842
17. Mehran R, Aymong ED, Nikolsky E et al (2004) A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44:1393-1399
18. Toprak O, Cirit M (2006) Risk factors for contrast-induced nephropathy. Kidney Blood Press Res 29:84-93
19. Pannu N, Wiebe N, Tonelli M (2006) Prophylaxis strategies for contrast-induced nephropathy. JAMA 295:2765-2779
20. Gleeson TG, Bulugahapitiya S (2004) Contrast-induced nephropathy. AJR 183:1673-1689
21. Rudnick MR, Goldfarb S, Wexler L et al (1995) Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int 47:254-261
22. Morcos SK, Thomsen HS, Webb JA (1999) Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol 9:1602-1613
23. McCullough PA, Soman SS (2005) Contrast-induced nephropathy. Crit Care Clin 21:261-280
24. Fliser D, Franek E, Joest M, Block S, Mutschler E, Ritz E (1997) Renal function in the elderly: impact of hypertension and cardiac function. Kidney Int 51:1196-1204
25. Rowe JW, Andres R, Tobin JD, Norris AH, Shock NW (1976) The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J Gerontol 31:155-163
26. Stevens LA, Coresh J, Levey AS (2008) CKD in the elderly-old questions and new challenges: World Kidney Day 2008. Am J Kidney Dis 51:353-357
27. Hemmelgarn BR, Zhang J, Manns BJ et al (2006) Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int 69:2155-2161
28. Naughton CA (2008) Drug-induced nephrotoxicity. Am Fam Physician 78:743-750
29. Nyman U, Bjork J, Aspelin P, Marenzi G (2008) Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention. Acta Radiol 49:658-667
30. Elicker BM, Cypel YS, Weinreb JC (2006) IV contrast administration for CT: a survey of practices for the screening and prevention of contrast nephropathy. AJR Am J Roentgenol 186:1651-1658
31. Ellis JH, Cohan RH (2009) Reducing the risk of contrast-induced nephropathy: a perspective on the controversies. AJR Am J Roentgenol 192:1544-1549
32. Bruce RJ, Djamali A, Shinki K, Michel SJ, Fine JP, Pozniak MA (2009) Background fluctuation of kidney function versus contrast-induced nephrotoxicity. AJR Am J Roentgenol 192:711-718
33. Cramer BC, Parfrey PS, Hutchinson TA et al (1985) Renal function following infusion of radiologic contrast material. A prospective controlled study. Arch Intern Med 145:87-89
34. Heller CA, Knapp J, Halliday J, O'Connell D, Heller RF (1991) Failure to demonstrate contrast nephrotoxicity. Med J Aust 155:329-332
35. Newhouse JH, Kho D, Rao QA, Starren J (2008) Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. AJR Am J Roentgenol 191:376-382
36. Barrett BJ, Katzberg RW, Thomsen HS et al (2006) Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol. Invest Radiol 41:815-821
37. Sandstede JJ, Roth A, Machann W, Kaupert C, Hahn D (2007) Evaluation of the nephrotoxicity of iodixanol in patients with predisposing factors to contrast medium induced nephropathy referred for contrast enhanced computed tomography. Eur J Radiol 63:120-123